Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 21, 2020; 26(23): 3170-3181
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3170
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3170
Table 1 Chemopreventive activities of urolithin A against colorectal cancer
| Cell line | Mechanism | Ref. |
| SW620 | ↓Proliferation, MMP-9 activity | Zhao et al[21] |
| ↑Autophagy, LC3 | ||
| G2/M arrest | ||
| ↑Apoptosis, necrosis | ||
| HT-29 | ↓Proliferation | Cho et al[22] |
| ↑Apoptosis, necrosis | ||
| G2/M arrest | ||
| ↑p21 expression | ||
| ↓MMP, ↑caspase 8 and 9 activity | ||
| HT-29 | ↓Proliferation | Kasimsetty et al[23] |
| ↓G0/G1 ↑G2/M, G0 | ||
| ↓CYP1 activity | ||
| ↑Apoptosis, caspase-3 like activity | ||
| HT-29 | ↓Proliferation | Tortora et al[24] |
| Caco-2 | CYP1A1, UGT1A10 | González-Sarrías et al[25] |
| CYP1A1 activity | ||
| 1Caco-2, HT-29, SW480 | ↓Proliferation | González-Sarrías et al[26] |
| S arrest (SW480, Caco-2) | ||
| G2/M arrest | ||
| Gene expression in Caco-2: | ||
| ↑ABCG2, TP53, c-MYC, CDKN1A, BIRC5 | ||
| Gene expression in SW480: | ||
| ↑c-MYC, CDKN1A, BIRC5, CASP3, EGFR | ||
| ↓CTNNB1 | ||
| Gene expression in HT-29: | ||
| ↑CDKN1A | ||
| Caco-2, HT-29, SW480 | ↓Proliferation | González-Sarrías et al[27] |
| G2/M (Caco-2, SW480, HT-29) | ||
| S (SW480, HT-29) arrest | ||
| HCT-116, Caco-2, HT-29 | ↓Colony formation | Giménez-Bastida et al[28] |
| G2/M arrest (Caco-2, HCT-116) | ||
| ↑Senescence-associated β–galactosidase activity (HCT-116) | ||
| ↑p53 and p21Cip1/Waf1 expression (HCT-116) | ||
| 1CSCs (Caco-2 and primary human colon tumor cells) | Caco-2: | Núñez-Sánchez et al[29] |
| ↓Colonosphere number | ||
| ↓ALDHhigh cells | ||
| Primary human colon tumor cells: | ||
| ↓Colonosphere number | ||
| ↓Colonosphere size | ||
| ↓ALDHhigh cells | ||
| HCT116 | ↓Cell growth | Norden et al[32] |
| ↑p53, p21, TIGAR expression | ||
| ↑p53, p21, TIGAR expression | ||
| Caco-2, HT-29, SW480 | ↓Proliferation | González-Sarrías et al[33] |
| ↑5-FU- and 5’-DFCR-induced cytotoxicity | ||
| G2/M arrest (Caco-2, SW480) | ||
| ↑Caspase 9 activity (Caco-2) | ||
| Caco-2 | NS cell vitality | Kojadinovic et al[36] |
| ↓ROS | ||
| ↓CAT activity | ||
| NS SOD and GPx activity | ||
| Caco-2 | ↓Proliferation | González-Sarrías et al[37] |
| Kinase signaling pathway gene expression: ↓FGFR2, ↑DUSP6, c-MYC, Fos, CD44 | ||
| Human tissue samples /pomegranate extract | ↓CD44, CTNNB1 CDKN1A, EGFR, TYMS | Nuñez-Sánchez et al[29,38] |
Table 2 Anti-inflammatory activity of urolithin A relevant to the intestine
| Cell line/model | Mechanism | Ref. |
| CCD18-Co/cytokine-induced inflammation IL-1β or TNF-α | ↓IL-1β-induced PGE2 level | Giménez-Bastida et al[41] |
| ↓IL-1β or TNF-α -stimulated migration | ||
| ↓non-stimulated migration | ||
| ↓IL-1β-stimulated adhesion | ||
| ↑TNF-α -decreased cell viability | ||
| ↓IL-1β or TNF-α -induced expression of members of the EGF, PGF, PDGF, VEGF, M-CSF, and IGF families | ||
| ↓IL-1β -induced PAI-1 and TNF-α -induced IL-8 levels | ||
| Fischer rats/DSS-induced colitis | ↑HCT, RBCs | Larrosa et al[42] |
| ↓Loss of epithelium, total histological scores | ||
| ↑Bifidobacteria | ||
| ↓E. coli, enterobacteria, and total aerobic bacteria CAT activity | ||
| ↓NO, iNOS | ||
| ↓PGE2, COX-2, PTGES | ||
| ↑Rb1, p53 ↓CD40, IL-1β and IL-4 | ||
| C57BL/6 x FVB F1/BRB intervention | ↑Shannon diversity index | Gu et al[44] |
| ↑Bacteroidetes, Barnesiella | ||
| ↓Firmicutes, Clostridium, Turicibacter, Lactobacillus | ||
| BMDMs/LPS | ↓IL-6, TNF-α level | Singh et al[45] |
| C57BL/6 mice | ↓LPS-induced serum level of IL-6, TNF-α | Singh et al[45] |
| ↑Colonic and hepatic Cyp1A1 activity in WT not in AhR−/− mice | ||
| ↑Colonic Cldn4, Nrf2, and NQO1 in WT not in AhR−/− and Nrf2−/− mice | ||
| ↑Colonic Cldn4, Nrf2, and NQO1 in WT not in AhR−/− and Nrf2−/− mice | ||
| HT-29, Caco-2 | ↑Cldn4, Ocln, and ZO1 | Singh et al[45] |
| ↑Cldn4, Ocln, and ZO1 | ||
| ↓LPS-induced leakage of FITC-dextran | ||
| ↑Cyp1A1, Cyp1A1 protein expression, and activity | ||
| ↑AhR-reporter, nuclear translocation of AhR | ||
| Cldn4 expression not affected in Ahr SiRNA and CYP1A1 SiRNA cells | ||
| ↑Nrf2 levels, nuclear translocation of Nrf2 | ||
| C57BL/6 mice/TNBS | ↓Weight loss, diseases activity index, intestinal permeability | Singh et al[45] |
| ↓Colonic MPO level | ||
| ↓Serum IL-6, TNF-α, CXCL1, and IL-1β levels | ||
| ↑Colon length, Cldn4 | ||
| ↓Tissue damage and inflammation scores | ||
| AhR-knockdown caco-2 cells/TCDD/IL-1β /TMF | ↓IL-6, CYP1A1, PTGS2 in siControl | Muku et al[47] |
| NS IL-6, CYP1A1, PTGS2 in siAhR |
Table 3 Chemopreventive activities of urolithin A against other cancers of the alimentary tract
| Cell line/model | Mechanism | Ref. |
| Liver | ||
| HepG2 | ↓Cell survival | Wang et al[50] |
| ↓Wnt/β-catenin signalling; β-catenin | ||
| ↓c-MYc, cyclin D1, phospo-c-Jun | ||
| ↓IL-6, IL-1β, NF-κβ, Cox-2, iNOS | ||
| ↑TP53, BAX, PUMA, NOXA, p53, phosphor-p53 | ||
| ↑Caspase-3, phospho-p38 | ||
| ↓H2O2-induced ROS, MDA level | ||
| ↑SOD level, GPx activity in H2O2-induced oxidative stress | ||
| HepG2.2.15 | ↓Cell proliferation | Qiu et al[51] |
| ↓Bcl-2 | ||
| ↑Cleaved caspase-3, Bax | ||
| ↓Lin28a, Zcchc11, Sp-1 | ||
| ↑Let-7a | ||
| ↓HMGA2, K-ras | ||
| ↓Invasive cell number | ||
| Cultured rat hepatocytes/t-BHT | ↓Cytotoxicity | Olennikov et al[55] |
| ↓LDH, MDA level | ||
| Pancreas | ||
| The human PDAC cell lines (MiaPaCa2, PANC1, AsPC1, CFPAC1, Capan1, Capan2, SW1990, HPAC, BxPC3) | ↓Cell proliferation, migration, apoptosis | Totiger et al[58] |
| ↓pAKT (T308), p70S6K (T421/S424), PDK1, pGSK3β, p4E-BP1 | ||
| PDAC xenografts in mice | ↓Tumor volume | Totiger et al[58] |
| ↓pAKT (T308), p70S6K (T421/S424) | ||
| ↓Ki67 | ||
| ↑Cleaved caspase-3 | ||
| PKT mice | ↓Tumor weight | Totiger et al[58] |
| ↑Survival | ||
| ↓pAKT (T308), p70S6K (T421/S424) | ||
| ↓Ki67 | ||
| ↑Cleaved caspase-3 | ||
| ↓F4/80-, Fox-P3, CD3- positive cells | ||
| Esophagus | ||
| BE patients/LBR intervention | ↑GST-pi level in BE biopsies | Kresty et al[59] |
- Citation: Kujawska M, Jodynis-Liebert J. Potential of the ellagic acid-derived gut microbiota metabolite – Urolithin A in gastrointestinal protection. World J Gastroenterol 2020; 26(23): 3170-3181
- URL: https://www.wjgnet.com/1007-9327/full/v26/i23/3170.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i23.3170
